Table 1.
Baseline patients characteristic of the included studies
| Author | Study design | Year of publication | Country | Sample size | Confirmed cases | Suspected cases | Age, years | Male (M): female (F), n | Monkeypox viral DNA test |
|---|---|---|---|---|---|---|---|---|---|
| Adler et al. 7 | Retrospective observational | 2022 | United Kingdom | 7 | 7 | 0 | 5 patients: 30–40 years; 1 patient: 40–50 years; 1 patient: less than 2 years |
M: 4 F: 3 |
PCR |
| Eseigbe et al. 17 | Case series | 2021 | North Central Nigeria | 2 | 2 | 0 | 20 years, 20 years | 2M | PCR |
| Reynolds et al. 18 | Case series | 2019 | Sierra Leone, West Africa | 2 | 2 | 0 | 11 months; 35 years | 2M | PCR |
| Eltvedt et al. 13 | Case report | 2020 | Democratic Republic of the Congo | 1 | 0 | 1 | 4 years | M | NR |
| Whitehouse et al. 20 | Surveillance data | 2021 | Democratic Republic of the Congo | 1057 | 1057 | 0 | 14 years | M: 568, F: 486, NR: 3 | PCR |
| Ngbolua et al. 21 | Cross sectional study | 2020 | Democratic Republic of the Congo | 3 | 3 | 0 | 13, 7.7 years | 3M | NR |
| Hobson et al. 19 | Case series | 2021 | United Kingdom | 3 | 3 | 0 | NR, NR, 18 months | NR | PCR |
| Yong et al. 15 | Case report | 2020 | Singapore | 1 | 1 | 0 | 38 years | M | PCR |
| Costello et al. 14 | Case report | 2022 | United States | 1 | 1 | 0 | 28 years | M | PCR |
| Hammerschlag et al. 16 | Case report | 2022 | Australia | 1 | 1 | 0 | 30 years | M | PCR |